Envoy Medical Inc. (COCH)
Envoy Medical Statistics
Share Statistics
Envoy Medical has 21.33M shares outstanding. The number of shares has increased by 8.64% in one year.
| Shares Outstanding | 21.33M |
| Shares Change (YoY) | 8.64% |
| Shares Change (QoQ) | 5.18% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.09M |
| Failed to Deliver (FTD) Shares | 200 |
| FTD / Avg. Volume | 1.03% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.29 and the forward PE ratio is -2.46. Envoy Medical's PEG ratio is 0.03.
| PE Ratio | -1.29 |
| Forward PE | -2.46 |
| PS Ratio | 119.42 |
| Forward PS | 1.3 |
| PB Ratio | -1.43 |
| P/FCF Ratio | -1.42 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Envoy Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of -1.04.
| Current Ratio | 1.24 |
| Quick Ratio | 1.02 |
| Debt / Equity | -1.04 |
| Debt / EBITDA | -0.99 |
| Debt / FCF | -1.04 |
| Interest Coverage | -23.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $5.36K |
| Profits Per Employee | $-495.12K |
| Employee Count | 42 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.43 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -67.95% in the last 52 weeks. The beta is 2.33, so Envoy Medical's price volatility has been higher than the market average.
| Beta | 2.33 |
| 52-Week Price Change | -67.95% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 2.08 |
| Relative Strength Index (RSI) | 53.65 |
| Average Volume (20 Days) | 19.5K |
Income Statement
In the last 12 months, Envoy Medical had revenue of 225K and earned -20.8M in profits. Earnings per share was -1.49.
| Revenue | 225K |
| Gross Profit | -517K |
| Operating Income | -19.26M |
| Net Income | -20.8M |
| EBITDA | -19.81M |
| EBIT | -19.98M |
| Earnings Per Share (EPS) | -1.49 |
Balance Sheet
The company has 5.48M in cash and 19.66M in debt, giving a net cash position of -14.18M.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 19.66M |
| Net Cash | -14.18M |
| Retained Earnings | -284.73M |
| Total Assets | 11.54M |
| Working Capital | 1.85M |
Cash Flow
In the last 12 months, operating cash flow was -17.95M and capital expenditures -980K, giving a free cash flow of -18.93M.
| Operating Cash Flow | -17.95M |
| Capital Expenditures | -980K |
| Free Cash Flow | -18.93M |
| FCF Per Share | -1.01 |
Margins
Gross margin is -229.78%, with operating and profit margins of -8558.22% and -9242.22%.
| Gross Margin | -229.78% |
| Operating Margin | -8558.22% |
| Pretax Margin | -9242.22% |
| Profit Margin | -9242.22% |
| EBITDA Margin | -8802.67% |
| EBIT Margin | -8558.22% |
| FCF Margin | -8412.89% |
Dividends & Yields
COCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for COCH is $9.12, which is 542.3% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.12 |
| Price Target Difference | 542.3% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -39.43 |
| Piotroski F-Score | 4 |